ES2059626T3 - Nuevos esteres de estramustina. - Google Patents

Nuevos esteres de estramustina.

Info

Publication number
ES2059626T3
ES2059626T3 ES89111062T ES89111062T ES2059626T3 ES 2059626 T3 ES2059626 T3 ES 2059626T3 ES 89111062 T ES89111062 T ES 89111062T ES 89111062 T ES89111062 T ES 89111062T ES 2059626 T3 ES2059626 T3 ES 2059626T3
Authority
ES
Spain
Prior art keywords
estramustine
esters
new
carbon atoms
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89111062T
Other languages
English (en)
Inventor
Bertil Valdemar Hansen
Per-Olov Gunnar Gunnarsson
Henri Rene Mollberg
Sven-Ake Johansson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Kabi Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia AB filed Critical Kabi Pharmacia AB
Application granted granted Critical
Publication of ES2059626T3 publication Critical patent/ES2059626T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/46—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

EL PRESENTE INVENTO CONCIERNE A NUEVOS SOMPUESTOS TENIENDO DE FORMULA GENERAL (I): DONDE R1, R2 Y R3 SON SELECCIONADOS DE GRUPO CONSISTENTE EN HIDROGENO O ALQUIL BAJO TENIENDO DE 1-4 ATOMOS DE CARBONO, DONDE R2 Y R3 JUNTO CON EL ATOMO DE N PUEDEN TAMBIEN FORMAR UN ANILLO TENIENDO DE 2-5 ATOMOS DE CARBONO Y DONDE N ES 0, 1 O 2, Y SALES FARMACEUTICAMENTE ACEPTABLES DE LO MISMO. LOS COMPONENTES DE ACUERDO CON EL INVENTO SON UTILES COMO AGENTES ANTICANCERIGENOS.
ES89111062T 1988-06-28 1989-06-19 Nuevos esteres de estramustina. Expired - Lifetime ES2059626T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8802402A SE8802402D0 (sv) 1988-06-28 1988-06-28 Novel esters

Publications (1)

Publication Number Publication Date
ES2059626T3 true ES2059626T3 (es) 1994-11-16

Family

ID=20372746

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89111062T Expired - Lifetime ES2059626T3 (es) 1988-06-28 1989-06-19 Nuevos esteres de estramustina.

Country Status (25)

Country Link
US (1) US5036062A (es)
EP (1) EP0351561B1 (es)
JP (1) JP2563587B2 (es)
KR (1) KR910000607A (es)
CN (1) CN1031060C (es)
AT (1) ATE96446T1 (es)
CA (1) CA1317587C (es)
DD (1) DD284026A5 (es)
DE (1) DE68910211T2 (es)
DK (1) DK318989A (es)
ES (1) ES2059626T3 (es)
FI (1) FI92707C (es)
HU (1) HU203766B (es)
IE (1) IE62462B1 (es)
IL (1) IL90724A0 (es)
LT (1) LT3548B (es)
LV (1) LV10235B (es)
MD (1) MD940402A (es)
NO (1) NO172939C (es)
NZ (1) NZ229649A (es)
PH (1) PH30437A (es)
PT (1) PT90986B (es)
RU (1) RU2036929C1 (es)
SE (1) SE8802402D0 (es)
ZA (1) ZA894716B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5209926A (en) * 1990-06-12 1993-05-11 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5252319A (en) * 1990-06-12 1993-10-12 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5256408A (en) * 1990-06-12 1993-10-26 Insite Vision Incorporated Aminosteroids for ophthalmic use
JP2520074B2 (ja) * 1992-06-11 1996-07-31 呉羽化学工業株式会社 新規なエストラジオ―ル誘導体−クロラムブチル結合体、その製造方法、及び医薬製剤
JPH07101977A (ja) * 1993-10-05 1995-04-18 Kureha Chem Ind Co Ltd ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
FR2717690B1 (fr) * 1994-03-24 1996-04-26 Roussel Uclaf Application de stéroïdes aromatiques 3 substitués par un aminoalcoxy substitué à l'obtention d'un médicament pour contrôler la stérilité, notamment masculine.
GB9419153D0 (en) * 1994-09-22 1994-11-09 Erba Carlo Spa Estramustine formulations with improved pharmaceutical properties
US20030108764A1 (en) * 2001-12-04 2003-06-12 Neill John Thomas Method for improving bonding of circuit board substrates to metal surfaces and the articles formed thereby
CN101463295B (zh) * 2008-11-28 2011-08-17 江苏海迅实业集团股份有限公司 半导体工业用清洗剂
US9745338B2 (en) 2013-07-11 2017-08-29 Evestra, Inc. Pro-drug forming compounds
BR112020007673A2 (pt) 2017-10-19 2020-10-13 Evestra, Inc. contraceptivos pró-fármaco de progestina de ação prolongada
CN112979744B (zh) * 2021-02-18 2022-02-15 齐齐哈尔医学院 具有抗肿瘤活性的薯蓣皂苷元拼合氮芥衍生物及其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1126386B (de) * 1959-11-14 1962-03-29 Hoechst Ag Verfahren zur Herstellung von Steroid-21-aminosaeureestern
US3299104A (en) * 1963-04-09 1967-01-17 Leo Ab Certain steroid nu-bis-(haloethyl)-carbamates
US4443440A (en) * 1982-08-30 1984-04-17 The Upjohn Company Amine containing ester prodrugs of corticosteroids
US4615835A (en) * 1983-11-17 1986-10-07 Stiftung Deutsches Krebsforschungs Zentrum Steroid esters of N-(2-halogenethyl)-N-nitroso-carbamoylamino and acids and peptides therefore, as well as method for preparing them
JPS617292A (ja) * 1984-06-20 1986-01-13 Japan Atom Energy Res Inst 制癌剤を結合させたエストラサイト系化合物を製造する方法

Also Published As

Publication number Publication date
DD284026A5 (de) 1990-10-31
AU3668289A (en) 1990-01-04
DE68910211T2 (de) 1994-05-11
FI92707C (fi) 1994-12-27
ZA894716B (en) 1990-03-28
LV10235A (lv) 1994-10-20
HU203766B (en) 1991-09-30
NO892672L (no) 1989-12-29
RU2036929C1 (ru) 1995-06-09
NZ229649A (en) 1991-12-23
AU607621B2 (en) 1991-03-07
DK318989A (da) 1989-12-29
IE891908L (en) 1989-12-28
FI893130A0 (fi) 1989-06-27
NO172939C (no) 1993-09-29
KR910000607A (ko) 1991-01-29
LV10235B (en) 1995-04-20
IE62462B1 (en) 1995-02-08
FI92707B (fi) 1994-09-15
LT3548B (en) 1995-11-27
MD940402A (ro) 1996-01-31
FI893130A (fi) 1989-12-29
CN1045792A (zh) 1990-10-03
PT90986B (pt) 1994-11-30
ATE96446T1 (de) 1993-11-15
CA1317587C (en) 1993-05-11
US5036062A (en) 1991-07-30
DE68910211D1 (de) 1993-12-02
EP0351561A1 (en) 1990-01-24
HUT52521A (en) 1990-07-28
NO172939B (no) 1993-06-21
CN1031060C (zh) 1996-02-21
EP0351561B1 (en) 1993-10-27
IL90724A0 (en) 1990-01-18
JP2563587B2 (ja) 1996-12-11
LTIP603A (en) 1995-01-31
PH30437A (en) 1997-05-09
PT90986A (pt) 1989-12-29
SE8802402D0 (sv) 1988-06-28
DK318989D0 (da) 1989-06-27
JPH0253795A (ja) 1990-02-22
NO892672D0 (no) 1989-06-27

Similar Documents

Publication Publication Date Title
ES2059626T3 (es) Nuevos esteres de estramustina.
SG49607A1 (en) 1-methylcarbapenem derivatives and process for preparation thereof
GB8705780D0 (en) Anticancer compounds
ATE50773T1 (de) Alkylresorcinolphosphite.
ZA913691B (en) Isochromane derivatives
ES8706610A1 (es) Proceso para preparar un derivado de aminoalcohol.
GB9119281D0 (en) Compound use and preparation
ATE105565T1 (de) Pradimicinderivate.
FI883507A0 (fi) Naftotiazepinderivat och deras framstaellning.
DE69327092D1 (de) Optisch aktives 1-phenylpyrrolidonderivat und dessen herstellung
ATE100449T1 (de) 1,3-dioxolan-benzoesaeure und derivate davon.
DK0455899T3 (da) Prostaglandin I-analog
ZA896121B (en) Antiinflammatory carbinoloimidazoles

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 351561

Country of ref document: ES